109 related articles for article (PubMed ID: 34564974)
1. Diagnostic value of combined detection of multiple tumor markers and blood lipid indexes in colorectal cancer and its prediction on adverse reactions of chemotherapy.
Jiang M; Ding G; Li G
J BUON; 2021; 26(4):1226-1230. PubMed ID: 34564974
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of Serum CEA, CA19-9, CA72-4, CA125 and Ferritin as Diagnostic Markers and Factors of Clinical Parameters for Colorectal Cancer.
Gao Y; Wang J; Zhou Y; Sheng S; Qian SY; Huo X
Sci Rep; 2018 Feb; 8(1):2732. PubMed ID: 29426902
[TBL] [Abstract][Full Text] [Related]
3. Combined detection of preoperative serum CEA, CA19-9 and CA242 improve prognostic prediction of surgically treated colorectal cancer patients.
Wang J; Wang X; Yu F; Chen J; Zhao S; Zhang D; Yu Y; Liu X; Tang H; Peng Z
Int J Clin Exp Pathol; 2015; 8(11):14853-63. PubMed ID: 26823815
[TBL] [Abstract][Full Text] [Related]
4. Predictive value of blood lipid association with response to neoadjuvant chemoradiotherapy in colorectal cancer.
Wang Y; Liu C; Zhang J; Liu Y; Gong G; Mo X; Liu P; Li B; Yin Y
Tumour Biol; 2016 Apr; 37(4):4955-61. PubMed ID: 26531721
[TBL] [Abstract][Full Text] [Related]
5. Applicative Value of Serum CA19-9, CEA, CA125 and CA242 in Diagnosis and Prognosis for Patients with Pancreatic Cancer Treated by Concurrent Chemoradiotherapy.
Gu YL; Lan C; Pei H; Yang SN; Liu YF; Xiao LL
Asian Pac J Cancer Prev; 2015; 16(15):6569-73. PubMed ID: 26434876
[TBL] [Abstract][Full Text] [Related]
6. CA125: A superior prognostic biomarker for colorectal cancer compared to CEA, CA19-9 or CA242.
Björkman K; Mustonen H; Kaprio T; Kekki H; Pettersson K; Haglund C; Böckelman C
Tumour Biol; 2021; 43(1):57-70. PubMed ID: 33935125
[TBL] [Abstract][Full Text] [Related]
7. [Prognostic value of combining preoperative serum tumor markers and peripheral blood routine indexes in patients with colorectal cancer].
Huang L; Fang J; Wu J; Zhou X; Wei H
Zhonghua Wei Chang Wai Ke Za Zhi; 2018 Dec; 21(12):1421-1426. PubMed ID: 30588596
[TBL] [Abstract][Full Text] [Related]
8. [Detection and clinical study of serum tumor markers in patients with colorectal cancer].
Zhao XW; Jiang B; Han CZ; Jing JX
Zhonghua Zhong Liu Za Zhi; 2005 May; 27(5):286-8. PubMed ID: 15996321
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of predictive markers for patients with advanced colorectal cancer.
Byström P; Berglund Å; Nygren P; Wernroth L; Johansson B; Larsson A; Glimelius B
Acta Oncol; 2012 Sep; 51(7):849-59. PubMed ID: 22974092
[TBL] [Abstract][Full Text] [Related]
10. Comparative analysis of tumor markers and evaluation of their predictive value in patients with colorectal cancer.
Liu ZP; Li LM; Liu XL; Zhang DX
Onkologie; 2012; 35(3):108-13. PubMed ID: 22414974
[TBL] [Abstract][Full Text] [Related]
11. The evaluation of diagnostic value of the tumor markers: CCSA-2 and CEA in colorectal cancer.
Knychalski B; Lukieńczuk T
Pol Przegl Chir; 2012 Feb; 84(2):86-92. PubMed ID: 22487741
[TBL] [Abstract][Full Text] [Related]
12. Usefulness of carcinoembryonic antigen for monitoring tumor progression during palliative chemotherapy in metastatic colorectal cancer.
Kim G; Jung EJ; Ryu CG; Hwang DY
Yonsei Med J; 2013 Jan; 54(1):116-22. PubMed ID: 23225807
[TBL] [Abstract][Full Text] [Related]
13. Combined detection tumor markers for diagnosis and prognosis of gallbladder cancer.
Wang YF; Feng FL; Zhao XH; Ye ZX; Zeng HP; Li Z; Jiang XQ; Peng ZH
World J Gastroenterol; 2014 Apr; 20(14):4085-92. PubMed ID: 24744600
[TBL] [Abstract][Full Text] [Related]
14. Lipid levels in serum and cancerous tissues of colorectal cancer patients.
Zhang X; Zhao XW; Liu DB; Han CZ; Du LL; Jing JX; Wang Y
World J Gastroenterol; 2014 Jul; 20(26):8646-52. PubMed ID: 25024621
[TBL] [Abstract][Full Text] [Related]
15. Elevated CA19-9 as the most significant prognostic factor in advanced colorectal carcinoma.
Kouri M; Pyrhönen S; Kuusela P
J Surg Oncol; 1992 Feb; 49(2):78-85. PubMed ID: 1738240
[TBL] [Abstract][Full Text] [Related]
16. Value of tumor markers in diagnosing and monitoring colorectal cancer and strategies for further improvement: analysis of 130 cases.
Chen C; Chen LQ; Yang GL; Li Y
Ai Zheng; 2007 Nov; 26(11):1221-6. PubMed ID: 17991322
[TBL] [Abstract][Full Text] [Related]
17. Carbohydrate antigen 242 highly consists with carbohydrate antigen 19-9 in diagnosis and prognosis of colorectal cancer: study on 185 cases.
Yang XQ; Chen C; Peng CW; Liu SP; Li Y
Med Oncol; 2012 Jun; 29(2):1030-6. PubMed ID: 21553105
[TBL] [Abstract][Full Text] [Related]
18. Association of serum levels of CEA, CA199, CA125, CYFRA21-1 and CA72-4 and disease characteristics in colorectal cancer.
Zhong W; Yu Z; Zhan J; Yu T; Lin Y; Xia ZS; Yuan YH; Chen QK
Pathol Oncol Res; 2015 Jan; 21(1):83-95. PubMed ID: 24875250
[TBL] [Abstract][Full Text] [Related]
19. Clinical significance and diagnostic value of serum NSE, CEA, CA19-9, CA125 and CA242 levels in colorectal cancer.
Luo H; Shen K; Li B; Li R; Wang Z; Xie Z
Oncol Lett; 2020 Jul; 20(1):742-750. PubMed ID: 32566000
[TBL] [Abstract][Full Text] [Related]
20. Clinical significance of plasma vascular endothelial growth factor in gastrointestinal cancer.
Hyodo I; Doi T; Endo H; Hosokawa Y; Nishikawa Y; Tanimizu M; Jinno K; Kotani Y
Eur J Cancer; 1998 Dec; 34(13):2041-5. PubMed ID: 10070308
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
